
Revag Biosciences Limited
About Revag Biosciences Limited
Data last updated:
Revag Biosciences Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 07 July 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PLC043602. Its GSTIN is 36AADCR2369D1ZH (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Laxminarayana Rau Praharaju and Rajyalakshmi Praharaju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 35E1 Phase 5 Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.41 Lakh. For the same year it recorded a net loss of ₹1.24 Lakh (net margin -87.8%) and EBITDA of ₹83,633 (EBITDA margin 59.3%). Revenue has declined at a compounded annual rate (CAGR) of 49% over five years.
As per MCA filings, the company has open charges of ₹5.5 Lakh and satisfied charges of ₹1.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Revag Biosciences has one previous CIN (Corporate Identification Number): U24239AP2004PLC043602. The current CIN is U24239TG2004PLC043602, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PLC043602 | Current |
| U24239AP2004PLC043602 | Previous |
Contact details
Revag Biosciences Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 35E1 Phase 5 Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Revag Biosciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Revag Biosciences Limited
FY 2025 filings availableRevag Biosciences Limited reported revenue of ₹1.41 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 49% over five years. EBITDA rose 246% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹83,633 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 59.3% | ||||
| Net Profit Margin | -87.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Revag Biosciences Limited, buy the company report.
Board of directors of Revag Biosciences Limited
Revag Biosciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Laxminarayana Rau Praharaju Also directs: Pherorovers Private Limited, Agbio Techmatrix Private Limited, A.G.Bio-Systems Private Limited and 1 more | Director | 07 Jul 2004 | 22 Years 3 Months | Current |
| Rajyalakshmi Praharaju Also directs: A.G.Bio-Systems Private Limited | Director | 21 Mar 2018 | 8 Years 7 Months | Current |
| Anurag Athreya Praharaju Also directs: Pherorovers Private Limited, Agbio Techmatrix Private Limited, A.G.Bio-Systems Private Limited and 4 more | Director | 21 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Revag Biosciences Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Biosciences, Preventive Healthcare Services), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aviom Medcare at Home Private Limited | ₹1.43 Lakh (FY 2025) | -86.0% | New Delhi, Delhi, India | |||
| Blissful Health Services Private Limited | ₹1.42 Lakh (FY 2024) | 2.0% | New Delhi, Delhi, India | |||
| Revag Biosciences Limitedthis company | ₹1.41 Lakh (FY 2025) | -₹1.24 Lakh | -87.8% | Hyderabad, Telangana, India | ||
| Yashoda Healthcare Private Limited | ₹1.39 Lakh (FY 2024) | 8.0% | New Delhi, Delhi, India | |||
| Primecare Global Private Limited | ₹1.37 Lakh (FY 2025) | 5.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Revag Biosciences Limited, buy the company report.
Auditor
Revag Biosciences Limited is audited by P MURALI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P MURALI & CO | FY 2023 | 007257S |
Shareholding
The shareholding of Revag Biosciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Revag Biosciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Sep 2020 | 100386942 | State Bank of India | ₹1.65 Cr | Satisfied | |
| 20 Mar 2015 | 10567567 | State Bank of Hyderabad | ₹5.5 Lakh | Satisfied |
To see the full charge records of Revag Biosciences Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Revag Biosciences Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revag Biosciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Revag Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCR2369D1ZH | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Revag Biosciences Limited, buy the company report.
Recent activity
Revag Biosciences Limited has 7 board changes on record since 2004: 3 appointments and 4 cessations. The latest: Anurag Athreya Praharaju ceased to be Additional Director on 29 Sep 2018.
2 earlier events are in the company report.
Frequently asked questions
Revag Biosciences is an active public limited company based in Hyderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 07 July 2004 (22+ years old) and is registered under CIN U24239TG2004PLC043602.
Revag Biosciences has 3 current directors:
- Laxminarayana Rau Praharaju - Director
- Rajyalakshmi Praharaju - Director
- Anurag Athreya Praharaju - Director
The latest financial statements of Revag Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Revag Biosciences is 36AADCR2369D1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of Revag Biosciences is U24239TG2004PLC043602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Revag Biosciences was incorporated on 07 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Revag Biosciences by revenue are Aviom Medcare at Home Private Limited, Blissful Health Services Private Limited, Yashoda Healthcare Private Limited, Primecare Global Private Limited, all in the Healthcare industry (Biosciences, Preventive Healthcare Services), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Anurag Athreya Praharaju ceased to be Additional Director on 29 Sep 2018. Rajyalakshmi Praharaju ceased to be Additional Director on 29 Sep 2018. Ratna Rao Vissa ceased to be Whole-Time Director on 26 Mar 2018. Revag Biosciences has 7 board changes on record in total.
The registered office of Revag Biosciences is at Plot No 35E1 Phase 5 Ida Cherlapally, Hyderabad, Telangana, India – 500051.
Revag Biosciences operates in the healthcare industry, in the preventive health services segment.
Revag Biosciences has open charges of ₹5.5 Lakh and satisfied charges of ₹1.7 Cr as per latest MCA filings.